Concurrent and Adjuvant PD-1 Blockade Combined With Induction Chemotherapy Plus Radiotherapy in Nasopharyngeal Carcinoma
Status:
Recruiting
Trial end date:
2026-08-01
Target enrollment:
Participant gender:
Summary
This is a phase 2, single-arm, multicenter clinical trial, with the purpose to evaluate the
therapeutic efficacy and safety of PD-1 Blockade combined with induction chemotherapy and
radiotherapy alone in high-risk locoregionally advanced nasopharyngeal carcinoma.